Insight Molecular Diagnostics (IMDX) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Insight Molecular Diagnostics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $5.7M and 0 sold $0 of IMDX stock on the open market.
Get emailed when insiders cluster-buy stocks like IMDX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IMDX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $2.7M | 6 | — | 0 |
| Q1 2026 | $3.0M | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Insight Molecular Diagnostics Inc. insiders reported open-market purchases totaling $5.7M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Broadwood Capital Inc (10% Owner) has the highest Insider Score at 87.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 280,38112,395,081 held (+2%) | $3.50 | $981K | -3.7% | — |
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 250,92312,684,884 held (+2%) | $3.64 | $913K | -7.4% | — |
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 38,88012,433,961 held (+0%) | $3.53 | $137K | -4.5% | — |
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 012,395,081 held (+0%) | — | $0 | — | — |
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 012,433,961 held (+0%) | — | $0 | — | — |
| Apr 27SEC | Broadwood Partners, L.P.10% Owner | Buy | 012,684,884 held (+0%) | — | $0 | — | — |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 102,05712,033,896 held (+1%) | $3.45 | $352K | -2.3% | 87 |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 40,69012,114,700 held (+0%) | $3.88 | $158K | -13.1% | 87 |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 40,11412,074,010 held (+0%) | $3.57 | $143K | -5.6% | 87 |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 012,033,896 held (+0%) | — | $0 | — | 87 |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 012,074,010 held (+0%) | — | $0 | — | 87 |
| Apr 20SEC | Broadwood Capital Inc10% Owner | Buy | 012,114,700 held (+0%) | — | $0 | — | 87 |
| Feb 12SEC | Neal C Bradsher10% Owner | Buy | 521,73911,931,839 held (+5%) | $5.75 | $3.0M | -41.4% | 30 |
| Feb 12SEC | Neal C Bradsher10% Owner | Buy | 011,931,839 held (+0%) | — | $0 | — | 30 |
Insiders at Insight Molecular Diagnostics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Neal C Bradsher10% Owner | $3.0M | — | Feb 12, 2026 | 30 |
| Broadwood Partners, L.P.10% Owner | $2.0M | — | Apr 27, 2026 | — |
| Broadwood Capital Inc10% Owner | $653K | — | Apr 20, 2026 | 87 |
IMDX stock: common questions
Are Insight Molecular Diagnostics Inc. insiders buying IMDX stock?
In the past 12 months, 3 insiders reported open-market purchases of IMDX worth $5.7M. The latest was 10% Owner Broadwood Partners, L.P. bought $981K of IMDX at $3.50 — first open-market purchase in our records.
Are Insight Molecular Diagnostics Inc. insiders selling IMDX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IMDX's 52-week range?
Over the past year IMDX has traded between $2.55 and $8.48. It last closed at $3.37 on Oct 9, 2026.